By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

The New England Journal of Medicine 

10 Shattuck Street

Boston  Massachusetts  02115-6094  U.S.A.
Phone: 617-734-9800 Fax: 617-739-9864


SEARCH JOBS


Industry
Services

Segment
Publisher





Company News
Study Published In The New England Journal of Medicine Finds Medtronic, Inc. (MDT) Insertable Cardiac Monitors Detect Atrial Fibrillation In Stroke Patients Better Than Standard Care 6/26/2014 8:32:51 AM
AstraZeneca PLC (AZN) Release: Data Published In The New England Journal of Medicine Demonstrate Naloxegol Improved Opioid-Induced Constipation In Chronic Pain Patients 6/19/2014 12:58:41 PM
Two-Year Results From Pfizer Inc. (PFE)’s XELJANZ® (Tofacitinib Citrate) ORAL Start Study Published In The New England Journal of Medicine 6/19/2014 11:20:11 AM
The Medicines Company (MDCO) Release: ORBACTIV™ (Oritavancin) Phase 3 Trial Results Published In The New England Journal of Medicine 6/5/2014 9:18:26 AM
The New England Journal of Medicine Publishes Data From Durata Therapeutics, Inc.  (DRTX)'s Discover Program 6/5/2014 9:09:16 AM
Medivation, Inc. (MDVN) Release: The New England Journal of Medicine Publishes Results From Phase 3 PREVAIL Trial Of Enzalutamide In Men With Chemotherapy-Naive Metastatic Prostate Cancer Progressing Despite Androgen Deprivation Therapy 6/2/2014 10:46:45 AM
Astellas Pharma Inc. (ALPMY) Release: The New England Journal of Medicine Publishes Results From Phase 3 PREVAIL Trial Of Enzalutamide In Men With Chemotherapy-Naïve Metastatic Prostate Cancer 6/2/2014 10:14:25 AM
The New England Journal of Medicine Publishes Results From Phase 3 PREVAIL Trial Of Enzalutamide In Men With Chemotherapy-Naive Metastatic Prostate Cancer Progressing Despite Androgen Deprivation Therapy 6/2/2014 9:18:04 AM
Ethicon, Inc. (JNJ)-Funded Study Confirming Long-Term Benefit Of Bariatric Surgery For Control Of Diabetes Published In The New England Journal of Medicine 5/27/2014 10:27:43 AM
Amgen (AMGN) Release: The New England Journal of Medicine Publishes Positive Proof-Of-Concept Data For New Asthma Treatment 5/21/2014 9:11:21 AM
12345678910...
//-->